Reviva to participate in the zacks small-cap research life sciences investor forum

Cupertino, calif., dec. 11, 2023 (globe newswire) -- reviva pharmaceuticals holdings, inc. (nasdaq: rvph) (“reviva” or the “company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (cns), inflammatory and cardiometabolic diseases, today announced that laxminarayan bhat, ph.d., founder, president, and ceo of reviva will participate live at the life sciences investor forum, hosted by virtualinvestorconferences.com, on december 14th, 2023. dr. bhat will engage in a “ceo chat” session with john vandermosten, senior biotechnology analyst with zacks small-cap research.
RVPH Ratings Summary
RVPH Quant Ranking